Innocan Pharma INNPF
OTC INNPF
$1.29 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Innocan Pharma (INNPF) Change in Other Operating Liabilities (2024 - 2025)

Updated

Innocan Pharma's Change in Other Operating Liabilities came in at $135,000 for the quarter ended Dec 31, 2025, compared with -$216,000 a year earlier.

Analysis

Innocan Pharma (INNPF) Change in Other Operating Liabilities (2024 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Innocan Pharma's Change in Other Operating Liabilities was $257,000.

  • Going back by year, Change in Other Operating Liabilities was $14,000 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.69 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -34.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -113.00 Mn
10 Innocan Pharma 5.78 Mn 1.73 Mn 4.43 Mn 135,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 135,000.00
Dec 31, 2024 -216,000.00
API Access

Innocan Pharma Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=INNPF&period=max&api_key=YOUR_API_KEY